Literature DB >> 16158078

Hypertriglyceridemia as a possible risk factor for prostate cancer.

L Wuermli1, M Joerger, S Henz, H-P Schmid, W F Riesen, G Thomas, W Krek, T Cerny, S Gillessen.   

Abstract

We retrospectively studied anthropometric and laboratory parameters (including serum triglycerides, cholesterol), as well as comedication in 504 patients diagnosed with prostate cancer between January 1997 and August 2002 at a single referral center, and compared these patients with 565 age-matched patients with benign prostatic hyperplasia. A positive correlation was found between serum triglycerides and prostate cancer (odds ratio: 1.148/mmol/l; 95% confidence interval (CI) 1.003-1.315; P<0.05) after correcting for age, body mass index, diabetes and comedication with statins. Hypertriglyceridemia may increase the risk of prostate cancer, and the prognostic relevancy of serum triglycerides should be studied prospectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158078     DOI: 10.1038/sj.pcan.4500834

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  20 in total

Review 1.  The metabolic syndrome: A high-risk state for cancer?

Authors:  Stephanie Cowey; Robert W Hardy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

2.  Serum omentin level in patients with prostate cancer.

Authors:  Ugur Uyeturk; Hasmet Sarıcı; Buket Kın Tekce; Muzaffer Eroglu; Eray Kemahlı; Ummugul Uyeturk; Adnan Gucuk
Journal:  Med Oncol       Date:  2014-03-23       Impact factor: 3.064

3.  Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

Review 4.  Metabesity and urological cancers.

Authors:  Ali Atan
Journal:  Turk J Urol       Date:  2017-12-01

5.  Serum total and HDL cholesterol and risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-09-14       Impact factor: 2.506

Review 6.  Metabolic syndrome and cancer.

Authors:  Pooja Pothiwala; Sushil K Jain; Subhashini Yaturu
Journal:  Metab Syndr Relat Disord       Date:  2009-08       Impact factor: 1.894

7.  Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China.

Authors:  Gabriella Andreotti; Idan Menashe; Jinbo Chen; Shih-Chen Chang; Asif Rashid; Yu-Tang Gao; Tian-Quan Han; Lori C Sakoda; Stephen Chanock; Philip S Rosenberg; Ann W Hsing
Journal:  Eur J Epidemiol       Date:  2009-11-04       Impact factor: 8.082

Review 8.  [Statins and probiotics in the prevention of urologic diseases].

Authors:  C Fischer; J Altwein
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

9.  Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China.

Authors:  Gabriella Andreotti; Jinbo Chen; Yu-Tang Gao; Asif Rashid; Shih-Chen Chang; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Kim N Danforth; Michelle D Althuis; Ann W Hsing
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

10.  Serum triglyceride concentrations and cancer risk in a large cohort study in Austria.

Authors:  H Ulmer; W Borena; K Rapp; J Klenk; A Strasak; G Diem; H Concin; G Nagel
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.